On Tuesday, May 13, 2025, the SCTO General Meeting of Members elected the SCTO organs for the 2025–2028 period, including a new President and a Steering Board member. During the General Assembly, a review of the SCTO’s 2024 activities, a look ahead to the new funding period, and updates from key stakeholders have been presented.

We invite you to explore the SCTO Annual Report 2024 and dive into the key achievements of our SCTO Clinical Trial Unit (CTU) Network and SCTO Platforms. The report highlights our efforts to strengthen harmonized clinical research through